Sleep Management in Cardiac Disease

Introduction to Sleep Management

• Melatonin is the preferred first-line sleep agent for patients with cardiac disease due to its favorable cardiovascular safety profile and efficacy in promoting sleep without adverse hemodynamic effects, as recommended by the American Society of Anesthesiologists and implied by the American Heart Association to help prevent delirium in cardiac patients 1

Benefits and Indications of Melatonin

• Melatonin preserves respiratory drive and may reduce delirium risk compared to benzodiazepines, according to the Society of Critical Care Medicine, and traditional sedative-hypnotics, such as zolpidem and eszopiclone, may worsen sleep-disordered breathing in patients with cardiac disease, as suggested by the European Society of Cardiology 2, 3

Sleep Apnea Assessment and Management

• Sleep apnea is common in cardiac patients, affecting 9% of women and 24% of men, and is associated with an increased risk of sudden cardiac death, especially with oxygen saturation <78%, as reported by the European Heart Association 3

Sedation Management

• Sedation is a crucial aspect of managing patients with cardiovascular disease, requiring careful consideration of hemodynamic effects and sedative choice, with recommendations from the European Society of Cardiology to consider potential interactions with cardiac medications, especially antiarrhythmics, and to withdraw any potentially arrhythmogenic medications 4, 5, 3
• High-dose opioids pose a risk of respiratory depression, which may exacerbate sleep apnea and increase the risk of sudden cardiac death, as warned by the European Heart Association, and should be used with caution 3
• Diazepam has minimal cardiac concerns and may be a safer hemodynamic sedative choice for patients with heart failure or cardiogenic shock due to its clinically insignificant effects on cardiac contractility and preserved cardiac output, as recommended by the European Society of Cardiology 4
• Benzodiazepines, such as midazolam, have a safer hemodynamic profile in patients with heart failure or cardiogenic shock, with a dose of 0.05-0.1 mg/kg IV, and provide effective amnesia, preferred over propofol due to less reduction in cardiac output and lower risk of severe hemodynamic instability 4
• Opiates, such as fentanyl, are safe due to their neutral effect on coronary vasomotion and beneficial reduction in myocardial oxygen consumption, with a recommended dose of 25-300 μg/h (0.5-5 μg/kg/h) 5, 4
• Propofol can be started at 5 μg/kg/min and titrated to effect, with a range of 5-50 μg/kg/min, and a maximum dose not exceeding 4 mg/kg/hour unless benefits outweigh risks, as recommended by the European Society of Intensive Care Medicine 4, 6
• Dexmedetomidine should be started at a lower dose (0.2 μg/kg/hr) without a loading dose, and titrated slowly to avoid bradycardia, as recommended by the American College of Critical Care Medicine 5

Sedative Characteristics

7, 6

Monitoring and Management of Sedation

• Continuous monitoring of oxygen saturation, blood pressure, cardiac rhythm, and respiratory rate and effort is essential during and after the procedure, with immediate availability of resuscitation equipment and personnel trained in advanced airway management, as recommended by the European Heart Journal and Circulation 5
• Validated sedation scales (e.g., Richmond Agitation-Sedation Scale) should be used, and drug-specific adverse effects should be monitored, such as blood pressure, triglycerides, and metabolic acidosis for propofol, and heart rate and blood pressure for dexmedetomidine, as recommended by the American College of Critical Care Medicine 6
• Daily sedation interruption protocols should be implemented to assess neurological status, as recommended by the Society of Critical Care Medicine and the American Thoracic Society 5, 8
• Regular evaluation of sedation levels using validated scales, and monitoring for signs of delirium every shift is recommended, as noted by the Society of Critical Care Medicine, and maintaining a regular light-dark cycle, reducing ICU noise, and frequently reorienting the patient can help optimize the environment, as recommended by the American College of Critical Care Medicine 6